Ching‐Chi Chiu

1.4k total citations
32 papers, 1.1k citations indexed

About

Ching‐Chi Chiu is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ching‐Chi Chiu has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Neurology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ching‐Chi Chiu's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological diseases and metabolism (5 papers) and Autophagy in Disease and Therapy (4 papers). Ching‐Chi Chiu is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological diseases and metabolism (5 papers) and Autophagy in Disease and Therapy (4 papers). Ching‐Chi Chiu collaborates with scholars based in Taiwan, United States and United Kingdom. Ching‐Chi Chiu's co-authors include Ann‐Joy Cheng, Yin‐Ju Chen, Tu‐Hsueh Yeh, Tzu‐Chen Yen, Hung‐Ming Wang, Chun‐Ta Liao, Joseph Tung‐Chieh Chang, Ya‐Ching Lu, Hung‐Li Wang and Chin-Song Lu and has published in prestigious journals such as PLoS ONE, Biomaterials and Cancer Research.

In The Last Decade

Ching‐Chi Chiu

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching‐Chi Chiu Taiwan 20 538 194 193 155 140 32 1.1k
Chen Duan China 14 290 0.5× 37 0.2× 106 0.5× 47 0.3× 87 0.6× 31 774
Tingting Lü China 20 501 0.9× 62 0.3× 126 0.7× 156 1.0× 130 0.9× 75 1.2k
Kathrin Barth Germany 18 392 0.7× 133 0.7× 69 0.4× 66 0.4× 71 0.5× 38 982
Zheng Lü China 14 339 0.6× 76 0.4× 30 0.2× 160 1.0× 98 0.7× 58 669
Xi Shi China 19 888 1.7× 33 0.2× 22 0.1× 199 1.3× 113 0.8× 60 1.5k
Georgios Tzimagiorgis Greece 17 677 1.3× 33 0.2× 18 0.1× 227 1.5× 147 1.1× 56 1.2k
Jia Feng China 23 712 1.3× 38 0.2× 166 0.9× 314 2.0× 115 0.8× 70 1.2k
Alberto Zambrano Spain 19 473 0.9× 59 0.3× 62 0.3× 65 0.4× 218 1.6× 34 1.0k
Nila Volpi Italy 16 313 0.6× 47 0.2× 191 1.0× 49 0.3× 92 0.7× 48 889

Countries citing papers authored by Ching‐Chi Chiu

Since Specialization
Citations

This map shows the geographic impact of Ching‐Chi Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Chi Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Chi Chiu more than expected).

Fields of papers citing papers by Ching‐Chi Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Chi Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Chi Chiu. The network helps show where Ching‐Chi Chiu may publish in the future.

Co-authorship network of co-authors of Ching‐Chi Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐Chi Chiu. A scholar is included among the top collaborators of Ching‐Chi Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐Chi Chiu. Ching‐Chi Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Joseph Tung‐Chieh, Guo-Rung You, Yi‐Chen Li, et al.. (2025). Drug Repurposing Targeting miRNA-mRNA Networks to Mitigate Areca Nut-Induced Head and Neck Cancer. Biomedical Journal. 100886–100886. 1 indexed citations
3.
Wang, Hung‐Li, Yi‐Chuan Cheng, Tu‐Hsueh Yeh, et al.. (2023). HCH6-1, an antagonist of formyl peptide receptor-1, exerts anti-neuroinflammatory and neuroprotective effects in cellular and animal models of Parkinson’s disease. Biochemical Pharmacology. 212. 115524–115524. 9 indexed citations
4.
Chen, Yi‐Chun, Shih‐Cheng Chang, Yun‐Shien Lee, et al.. (2023). TOMM40 Genetic Variants Cause Neuroinflammation in Alzheimer’s Disease. International Journal of Molecular Sciences. 24(4). 4085–4085. 20 indexed citations
6.
Lee, Cheng‐Hung, Julien G. Roth, Ching‐Chi Chiu, et al.. (2022). Tuning pro-survival effects of human induced pluripotent stem cell-derived exosomes using elastin-like polypeptides. Biomaterials. 291. 121864–121864. 7 indexed citations
7.
Yeh, Tu‐Hsueh, Ching‐Chi Chiu, Mei‐Ling Cheng, et al.. (2021). PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia–parkinsonism type 14 and can be relieved by DHA treatment in animal models. Experimental Neurology. 346. 113863–113863. 6 indexed citations
8.
Wang, Hung‐Li, Ying‐Zu Huang, Yi‐Hsin Weng, et al.. (2020). Alda-1, an activator of ALDH2, ameliorates Achilles tendinopathy in cellular and mouse models. Biochemical Pharmacology. 175. 113919–113919. 23 indexed citations
9.
Chiu, Ching‐Chi, Yi-Hsin Weng, Ying‐Zu Huang, et al.. (2020). (D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model. Cell Death and Disease. 11(11). 1018–1018. 36 indexed citations
10.
Chiu, Ching‐Chi, Rou-Shayn Chen, Hua-Chien Chen, et al.. (2019). Upregulated Expression of MicroRNA-204-5p Leads to the Death of Dopaminergic Cells by Targeting DYRK1A-Mediated Apoptotic Signaling Cascade. Frontiers in Cellular Neuroscience. 13. 399–399. 42 indexed citations
11.
Chiu, Ching‐Chi, Hung‐Li Wang, Yi‐Hsin Weng, et al.. (2019). Generation of induced pluripotent stem cells from a young-onset Parkinson's disease patient carrying the compound heterozygous PLA2G6 p.D331Y/p.M358IfsX mutations. Stem Cell Research. 40. 101552–101552. 3 indexed citations
13.
Cheng, Yi‐Chuan, Tu‐Hsueh Yeh, Hung‐Yu Shih, et al.. (2015). Deltex1 is inhibited by the Notch–Hairy/E(Spl) signaling pathway and induces neuronal and glial differentiation. Neural Development. 10(1). 28–28. 12 indexed citations
14.
Chiu, Ching‐Chi, Tu‐Hsueh Yeh, Szu‐Chia Lai, et al.. (2014). Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism. Experimental Neurology. 263. 244–253. 69 indexed citations
15.
Chiu, Ching‐Chi, Chien‐Yu Lin, Li‐Yu Lee, et al.. (2011). Molecular Chaperones as a Common Set of Proteins That Regulate the Invasion Phenotype of Head and Neck Cancer. Clinical Cancer Research. 17(14). 4629–4641. 50 indexed citations
16.
Chang, Joseph Tung‐Chieh, Hung‐Ming Wang, Shih‐Hsuan Chan, et al.. (2010). Proteomics of the Radioresistant Phenotype in Head-and-Neck Cancer: Gp96 as a Novel Prediction Marker and Sensitizing Target for Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 78(1). 246–256. 47 indexed citations
17.
Kang, Chung‐Jan, Yin‐Ju Chen, Chun‐Ta Liao, et al.. (2009). Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer. Cancer Letters. 284(2). 131–140. 19 indexed citations
18.
Lin, Chien‐Yu, Chun‐Ta Liao, I‐How Chen, et al.. (2009). Positive association of glucose‐regulated protein 78 during oral cancer progression and the prognostic value in oral precancerous lesions. Head & Neck. 32(8). 1028–1039. 32 indexed citations
19.
Chen, Yin‐Ju, Joseph Tung‐Chieh Chang, Chun‐Ta Liao, et al.. (2008). Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Science. 99(8). 1507–1514. 251 indexed citations
20.
Chiu, Ching‐Chi & Ann‐Joy Cheng. (2007). Grp78 is over-expressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Cancer Research. 67. 4282–4282. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026